# Annovis Bio, Inc.: Form 8-K, filed Mar 16, 2026

- Company: [Annovis Bio, Inc.](/companies/anvs.md) (CIK 1477845)
- Form: 8-K
- Filed: 2026-03-16
- Accepted by EDGAR: Mar 16, 2026, 17:06 ET
- Period: 2026-03-16
- Accession: 0001104659-26-028574
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1477845/000110465926028574/tm268976d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1477845/000110465926028574/

## Items reported

- Item 2.02: Results of operations
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1477845/000110465926028574/tm268976d1_8k.htm

Filed Mar 16, 2026.
Source: SEC EDGAR, the filing index for accession 0001104659-26-028574. Last ingested by Listed: Nov 5, 2026, 21:06 ET. No prices; not investment advice.